2018年心脏分配制度变更对以耐久性左心室辅助装置作为移植桥梁患者结局的影响:一项UNOS登记分析
本研究利用器官共享联合网络(UNOS)数据库,比较2018年10月18日心脏分配政策变更前后以耐久性左心室辅助装置(LVAD)等待原位心脏移植的成年候选者的结局。结果显示两时期等待名单2年生存率、移植累积发生率及因死亡或临床恶化除名率相似;移植后2年生存率相似,但新政策时期移植后卒中、需透析的肾衰竭发生率更高且住院时间更长。
要点
- 新旧政策时期LVAD候选者等待名单2年生存率相似
- 移植累积发生率及因死亡或临床恶化除名率在兩时期相似
- 新政策时期移植后卒中、需透析肾衰竭更多、住院时间更长,但2年生存率未受影响
核心结论
- 2018年心脏分配政策对耐久性LVAD支持候选者自首次等待名单起的总体生存无显著影响,移植累积发生率与等待名单死亡率也基本未变;接受移植者观察到更高程度的移植后并发症,但生存未受影响。
研究设计与样本
- 研究为基于UNOS数据库的登记分析,纳入在季节匹配、等长时间段内列名的两组成年耐久性LVAD候选者,即旧政策时期(OPE)与新政策时期(NPE)。
- 等待名单候选者共2,512例,OPE 1,253例、NPE 1,259例;研究期间移植患者共2,560例,OPE 1,418例、NPE 1,142例。
主要发现
- 两政策下候选者等待名单后2年生存率相似,移植累积发生率及因死亡和/或临床恶化除名率也相似。
- 移植后2年生存率在两政策时期之间相似,但NPE与更高的移植后卒中、需透析的肾衰竭发生率及更长住院时间相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study compared outcomes of patients waitlisted for orthotopic heart transplantation with durable left ventricular assist devices (LVAD) before and after the October 18, 2018 heart allocation policy change. METHODS: The United Network of Organ Sharing database was queried to identify 2 cohorts of adult candidates with durable LVAD listed within seasonally-matched, equal-length periods before (old policy era [OPE]) and after the policy change (new policy era [NPE]). The primary outcomes were 2-year survival from the time of initial waitlisting, as well as 2-year post-transplant survival. Secondary outcomes included incidence of transplantation from the waitlist and de-listing due to either death or clinical deterioration. RESULTS: A total of 2,512 candidates were waitlisted, 1,253 within the OPE and 1,259 within the NPE. Candidates under both policies had similar 2-year survival after waitlisting, as well as a similar cumulative incidence of transplantation and de-listing due to death and/or clinical deterioration. A total of 2,560 patients were transplanted within the study period, 1,418 OPE and 1,142 within the NPE. Two-year post-transplant survival was similar between policy eras, however, the NPE was associated with a higher incidence of post-transplant stroke, renal failure requiring dialysis, and a longer hospital length of stay. CONCLUSIONS: The 2018 heart allocation policy has conferred no significant impact on overall survival from the time of initial waitlisting among durable LVAD-supported candidates. Similarly, the cumulative incidence of transplantation and waitlist mortality have also been largely unchanged. For those undergoing transplantation, a higher degree of post-transplant morbidity was observed, though survival was not impacted.
引用
- Hess NR, Ziegler LA, Keebler ME, et al. Impact of 2018 allocation system change on outcomes in patients with durable left ventricular assist device as bridge to transplantation: A UNOS registry analysis. J Heart Lung Transplant. 2023. PMID: 36973093. doi:10.1016/j.healun.2023.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。